Humanscape
Accompanying rare disease patients on their journey towards a cure
Accompanying rare disease patients on their journey towards a cure
Humanscape is a health-tech company focused on leveraging patient data for the advancement of new drug development, research, diagnosis, and more. Founded in 2016 and headquartered in South Korea, the company operates within the industries of Big Data, Blockchain, Health Care, and Information Technology. In its latest funding round on 12 May 2023, Humanscape secured a KRW20.00B Series C investment from a consortium of prominent investors including MINT Venture Partners, UTC Investment, Hana Financial Investment, Kyobo Securities, Shinhan Bank, Carelabs, Shinhan Asset Management, and Green Cross Holding. As the company's slogan suggests, it is dedicated to accompanying rare disease patients on their journey towards a cure, presenting significant potential in the ever-evolving health-tech landscape.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series C | KRW20.00B | 8 |
|
12 May 2023 |
| Series C | KRW15.00B | 1 | Kakao Corp | 18 Nov 2021 |
| Series B | $11.80M | 6 |
|
08 Dec 2020 |
| Venture Round | Unknown | 1 |
|
09 Mar 2020 |
| Venture Round | $840.00K | 1 |
|
04 Nov 2019 |
No recent news or press coverage available for Humanscape.
We care about your data, and we'd love to use cookies make your experience better.
